Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Nausea and vomiting (pregnancy) (Prochlorperazine maleate - Nausea and vomiting (pregnancy))

Records returned : 15 (on 04 Aug 2026 at 04:36:13). Return to search results for ' Nausea and vomiting (pregnancy) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Prochlorperazine maleate

Drug:

Prochlorperazine maleate

Indication :

Nausea and vomiting (pregnancy)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line treatment option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

2. Prochlorperazine maleate

Drug:

Prochlorperazine maleate

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Buccal/sublingual

Restrictions / Comments:

Important

An option for patients with swallowing difficulties

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

3. Chlorpromazine hydrochloride

Drug:

Chlorpromazine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line treatment option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

7. Chlorpromazine hydrochloride

Drug:

Chlorpromazine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Important

An option for patients with swallowing difficulties.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

4. Cyclizine hydrochloride

Drug:

Cyclizine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line treatment option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

5. Promethazine hydrochloride

Drug:

Promethazine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line treatment option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

14. Promethazine hydrochloride

Drug:

Promethazine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Important

An option for patients with swallowing difficulties

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

6. Promethazine teoclate

Drug:

Promethazine teoclate

Indication :

Nausea and vomiting (pregnancy)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

1st line treatment option.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

8. Domperidone

Drug:

Domperidone

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Oral suspension
Oro-dispersible tablets
Tablets

Restrictions / Comments:

Important

Safety alert and cardiac side-effects.

Domperidone: risks of cardiac side effects - GOV.UK

https://www.gov.uk/drug-safety-update/domperidone-risks-of-cardiac-side-effects

2nd line treatment option but should not be prescribed for longer than 7 days.

Note - orodispersible 10mg tablets are a cost-effective alternative to the oral suspension and should be considered in preference to oral suspension for patients with swallowing difficulties.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

9. Doxylamine succinate/pyridoxine hydrochloride

Drug:

Doxylamine succinate/pyridoxine hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Gastro-resistant tablets

Restrictions / Comments:

Important

Not a preferred 1st-line option. Use only after failure of at least one established 1st-line treatment options

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

10. Metoclopramide hydrochloride

Drug:

Metoclopramide hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

2nd line treatment option. Should not be prescribed for longer than 5 days.

Metoclopramide: risk of neurological adverse effects - GOV.UK

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

11. Metoclopramide hydrochloride

Drug:

Metoclopramide hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Important

2nd line treatment option. Should not be prescribed for longer than 5 days.

Metoclopramide: risk of neurological adverse effects - GOV.UK

An option in patients with swallowing difficulties.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

12. Ondansetron hydrochloride

Drug:

Ondansetron hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

Off Label

SPC

13. Ondansetron hydrochloride

Drug:

Ondansetron hydrochloride

Indication :

Nausea and vomiting (pregnancy)

Status :

Green (see narrative)

Formulations :

Orodispersible films

Restrictions / Comments:

Important

An option in patients with swallowing difficulties. 2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :